0001485003-18-000096.txt : 20180614 0001485003-18-000096.hdr.sgml : 20180614 20180614164642 ACCESSION NUMBER: 0001485003-18-000096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180612 FILED AS OF DATE: 20180614 DATE AS OF CHANGE: 20180614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HURLY STEPHEN A CENTRAL INDEX KEY: 0001130637 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 18899707 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS STREET 2: 215 FIRST ST. #400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 4 1 wf-form4_152900918587429.xml FORM 4 X0306 4 2018-06-12 0 0001485003 Sesen Bio, Inc. SESN 0001130637 HURLY STEPHEN A C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 1 1 0 0 President and CEO Employee Stock Option (Right to Buy) 1.59 2018-06-12 4 A 0 87150 0 A 2027-10-03 Common Stock 87150.0 272580 D On October 4, 2017, the reporting person was granted an option to purchase 420,000 shares of common stock. This option vests in installments based on the achievement of certain strategic and clinical milestones. On June 12, 2018, the Compensation Committee of the Board of Directors of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 87,150 shares. /s/ Stephen A. Hurly 2018-06-14